NEW YORK (GenomeWeb) – Biocept reported after the close of the market on Tuesday that its fourth quarter revenues rose nearly 500 percent year over year.

For the three months ended Dec. 31, the company's total revenues rose to $1.3 million from $218,283 in the prior-year quarter. Within its overall revenue, $1.2 million came from commercial testing and another $70,000 was from the firm's development services.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.